EPISODE · Apr 27, 2026 · 11 MIN
Episode 51: Treating Relapsed/Refractory CLL
from Healthcare Unfiltered Express · host Chadi Nabhan
Dr. Matt Davids of the Dana Farber Cancer Institute joins Healthcare Unfiltered EXPRESS to share his data-solidified insights on navigating the treatment of relapsed/refractory (R/R) CLL, considering the welcome advances the field has witnessed in treating front-line disease. Check it out, subscribe, rate, and join the conversation.
Embed this episode
NOW PLAYING
Episode 51: Treating Relapsed/Refractory CLL
No transcript for this episode yet
Similar Episodes
No similar episodes found.